Clinical Trial Update: Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage [Phase 4]

View source ↗

Summary

Phase 4 trial comparing misoprostol 400 µg versus 200 µg for cervical ripening in first-trimester miscarriage; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage in the First Trimester

Drugs mentioned

• misoprostol 200 µg (misoprostol)
• misoprostol 400 µg (misoprostol)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Miscarriage in First Trimester | Phase 4 | Status: COMPLETED | Results posted: 2020-09-03